1. Home
  2. ORMP vs LICN Comparison

ORMP vs LICN Comparison

Compare ORMP & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
    SELLHOLDBUYas of 8 hours ago
  • LICN
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • ORMP 2002
  • LICN 2004
  • Country
  • ORMP United States
  • LICN China
  • Employees
  • ORMP N/A
  • LICN N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • ORMP Health Care
  • LICN
  • Exchange
  • ORMP Nasdaq
  • LICN Nasdaq
  • Market Cap
  • ORMP 84.3M
  • LICN 22.9K
  • IPO Year
  • ORMP N/A
  • LICN 2023
  • Fundamental
  • Price
  • ORMP $2.39
  • LICN $4.35
  • Analyst Decision
  • ORMP Hold
  • LICN
  • Analyst Count
  • ORMP 1
  • LICN 0
  • Target Price
  • ORMP N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • ORMP 213.8K
  • LICN 147.8K
  • Earning Date
  • ORMP 05-08-2025
  • LICN 01-01-0001
  • Dividend Yield
  • ORMP N/A
  • LICN N/A
  • EPS Growth
  • ORMP N/A
  • LICN 36.90
  • EPS
  • ORMP 0.11
  • LICN 55.10
  • Revenue
  • ORMP N/A
  • LICN $41,929,000.00
  • Revenue This Year
  • ORMP N/A
  • LICN N/A
  • Revenue Next Year
  • ORMP N/A
  • LICN N/A
  • P/E Ratio
  • ORMP $22.57
  • LICN $0.09
  • Revenue Growth
  • ORMP N/A
  • LICN 24.86
  • 52 Week Low
  • ORMP $1.96
  • LICN $0.04
  • 52 Week High
  • ORMP $3.14
  • LICN $7.55
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 53.29
  • LICN 68.15
  • Support Level
  • ORMP $2.42
  • LICN $4.52
  • Resistance Level
  • ORMP $2.68
  • LICN $5.77
  • Average True Range (ATR)
  • ORMP 0.15
  • LICN 0.45
  • MACD
  • ORMP 0.04
  • LICN 0.23
  • Stochastic Oscillator
  • ORMP 59.72
  • LICN 57.41

Stock Price Comparison Chart: ORMP vs LICN

ORMP
LICN
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025050100150200250300350400ORMP VS LICN

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About LICN Lichen China Limited

Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use